Coronavirus Update: Synairgen Tests First Inhaled Candidate, No New China Cases

While Survey Shows Looming Crisis In Trial Recruitment

More studies are being launched into possible treatments for patients hospitalised with COVID-19, with Roche launching a Phase III, placebo-controlled trial of Actemra.

Gold_Coast_Hospital
Gold Coast University Hospital, Australia. The country is now restricting entry to foreigners in an attempt to prevent escalation in COVID-19 infections

COVID-19 can prove fatal for the elderly and those with underlying health conditions, with most acute cases developing pneumonia and respiratory problems, but so far no inhaled treatment is available to target the lung infection.

Now small UK biotech Synairgen PLC has stepped forward, and is to start a Phase II trial in COVID-19...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip